Suchergebnisse - Glucose-lowering agents

1

A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?

von: Maitra, Neil S.

2022, in: Current cardiology reports

Wird geladen...
2

Clinical pharmacology of antidiabetic drugs: What can be expected of their use?

von: Scheen, André J.

2022, in: No title available

Wird geladen...
3

Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?

von: Monami, Matteo

2015, in: Current Cardiovascular Risk reports

Wird geladen...
4

Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1

von: Baggio, Laurie L.

2002, in: Treatments in Endocrinology

Wird geladen...
5

Can patterns of medication use explain the increasing incidence of end stage kidney disease among people with diabetes in Australia?

von: Buyadaa, Oyunchimeg

2021, in: Rewritable superhemophobic and superhemophilic wettability pattern based on titanium dioxide with Ag loading

Wird geladen...
6

An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations

von: Bae, Jay P.

2022, in: Diabetes therapy

Wird geladen...
7

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure

von: Bowker, S. L.

2010, in: Diabetologia

Wird geladen...
8

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

von: Rosenstock, J.

2008, in: Diabetologia

Wird geladen...
9

Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues

von: Miriam Longo

2022, in: Biomolecules

Wird geladen...
10

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

von: Biessels, Geert Jan

2018, in: BMC neurology

Wird geladen...
11

Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87)

von: Agbaje, Olorunsola F.

2020, in: Rewritable superhemophobic and superhemophilic wettability pattern based on titanium dioxide with Ag loading

Wird geladen...
12

Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I

von: Raquel Vieira

2019, in: Pharmaceuticals

Wird geladen...
13

Sex-specific differences in diabetes prevention: a systematic review and meta-analysis

von: Glechner, Anna

2014, in: Diabetologia

Wird geladen...
14

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials

von: Tanaka, Atsushi

2019, in: Cardiovascular diabetology

Wird geladen...
15

Diabetes, bone and glucose-lowering agents: clinical outcomes

von: Schwartz, Ann V.

2017, in: Diabetologia

Wird geladen...
16

Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory

von: Bonora, Enzo

2021, in: Surfactant-assisted combustion synthesis of agglomerated-free, size- and shape-controlled magnetic iron oxide nanoparticles for biomedical applications

Wird geladen...
17

The future of new drugs for diabetes management

von: Bailey, Clifford J.

2019transfer abstract, in: Rewritable superhemophobic and superhemophilic wettability pattern based on titanium dioxide with Ag loading

Wird geladen...
18

Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes

von: Thomsen, Reimar W.

2015, in: Diabetologia

Wird geladen...
19

Utilization of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacoepidemiological Studies: A Systematic Review on Antiarrhythmic and Glucose-Lowering Medicines

von: Soroush Mohammadi Jouabadi

2022, in: Frontiers in Pharmacology

Wird geladen...
20

Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials

von: Chrysi Koliaki

2019, in: International Journal of Environmental Research and Public Health

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!